Modulation of Chaperone Function and Cochaperone Interaction by Novobiocin in the C-terminal Domain of Hsp90

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Biological Chemistry

• Publication date

  2006-03-17

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1074/jbc.M512406200PMID 16421106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomic analysis identifies immunophilin FK506 binding protein 4 (FKBP52) as a downstream target of Hoxa10 in the periimplantation mouse uterus.

  2005cited by this paper
• Structure-function analysis of squirrel monkey FK506-binding protein 51, a potent inhibitor of glucocorticoid receptor activity.

  2005cited by this paper
• Physiological role for the cochaperone FKBP52 in androgen receptor signaling.

  2005cited by this paper
• FK506-binding Proteins 51 and 52 Differentially Regulate Dynein Interaction and Nuclear Translocation of the Glucocorticoid Receptor in Mammalian Cells*

  2005cited by this paper
• Hsp90 inhibitors identified from a library of novobiocin analogues.

  2005cited by this paper
• Nucleotide-dependent Domain Movement in the ATPase Domain of a Human Type IIA DNA Topoisomerase*

  2005cited by this paper
• Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation.

  2005cited by this paper
• The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37).

  2004cited by this paper
• Altered states: selectively drugging the Hsp90 cancer chaperone.

  2004cited by this paper
• Androgen receptor in prostate cancer.

  2004cited by this paper
• Novobiocin induces a distinct conformation of Hsp90 and alters Hsp90-cochaperone-client interactions.

  2004cited by this paper
• Tetratricopeptide repeat cochaperones in steroid receptor complexes

  2004cited by this paper
• Functional Specificity of Co-Chaperone Interactions with Hsp90 Client Proteins

  2004cited by this paper
• The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site.

  2004cited by this paper
• The heat shock protein 90-targeting drug cisplatin selectively inhibits steroid receptor activation.

  2003cited by this paper
• Heat shock protein 90

  2003cited by this paper
• Immunophilin chaperones in steroid receptor signalling.

  2003cited by this paper
• A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

  2003cited by this paper
• The Hsp90‐binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo

  2003cited by this paper
• C-terminal Sequences outside the Tetratricopeptide Repeat Domain of FKBP51 and FKBP52 Cause Differential Binding to Hsp90*

  2003cited by this paper
• Structure and functional relationships of Hsp90.

  2003cited by this paper
• Degradation of HER2 by ansamycins induces growth arrest and apoptosis in cells with HER2 overexpression via a HER3, phosphatidylinositol 3'-kinase-AKT-dependent pathway.

  2002cited by this paper
• Binding of ATP to Heat Shock Protein 90

  2002cited by this paper
• A Nucleotide-dependent Molecular Switch Controls ATP Binding at the C-terminal Domain of Hsp90

  2002cited by this paper
• 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts.

  2002cited by this paper
• A New First Step in Activation of Steroid Receptors

  2002cited by this paper
• A Structure-based Mutational Analysis of Cyclophilin 40 Identifies Key Residues in the Core Tetratricopeptide Repeat Domain That Mediate Binding to Hsp90*

  2002cited by this paper
• Regulation of Heat Shock Protein 90 ATPase Activity by Sequences in the Carboxyl Terminus*

  2002cited by this paper
• A hydrophobic segment within the C-terminal domain is essential for both client-binding and dimer formation of the HSP90-family molecular chaperone.

  2002cited by this paper
• Localization of the Chaperone Domain of FKBP52*

  2001cited by this paper
• Two structures of cyclophilin 40: folding and fidelity in the TPR domains.

  2001cited by this paper
• Hsp90 Regulates p50 cdc37 Function during the Biogenesis of the Active Conformation of the Heme-regulated eIF2α Kinase*

  2001cited by this paper
• Serine / threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling

  2001cited by this paper
• Collocation of androgen receptor gene mutations in prostate cancer.

  2001cited by this paper
• Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine.

  2000cited by this paper
• Dimerization and N-terminal domain proximity underlie the function of the molecular chaperone heat shock protein 90.

  2000cited by this paper
• Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins.

  2000cited by this paper
• Overlapping Sites of Tetratricopeptide Repeat Protein Binding and Chaperone Activity in Heat Shock Protein 90*

  2000cited by this paper
• The Heat Shock Protein 90 Antagonist Novobiocin Interacts with a Previously Unrecognized ATP-binding Domain in the Carboxyl Terminus of the Chaperone*

  2000cited by this paper
• The ATPase cycle of Hsp90 drives a molecular ‘clamp’ via transient dimerization of the N‐terminal domains

  2000cited by this paper
• KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.

  1999cited by this paper
• The Common Tetratricopeptide Repeat Acceptor Site for Steroid Receptor-associated Immunophilins and Hop Is Located in the Dimerization Domain of Hsp90*

  1999cited by this paper
• A novel chaperone-activity-reducing mechanism of the 90-kDa molecular chaperone HSP90.

  1999cited by this paper
• Identification of Conserved Residues Required for the Binding of a Tetratricopeptide Repeat Domain to Heat Shock Protein 90*

  1999cited by this paper
• Delimitation of two regions in the 90-kDa heat shock protein (Hsp90) able to interact with the glucocorticosteroid receptor (GR).

  1999cited by this paper
• Differential interactions of p23 and the TPR-containing proteins Hop, Cyp40, FKBP52 and FKBP51 with Hsp90 mutants.

  1998cited by this paper
• Specific Binding of Tetratricopeptide Repeat Proteins to the C-terminal 12-kDa Domain of hsp90*

  1998cited by this paper
• Two chaperone sites in Hsp90 differing in substrate specificity and ATP dependence.

  1998cited by this paper
• Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone.

  1997cited by this paper
• Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent.

  1997cited by this paper
• Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor

  1997cited by this paper
• Steroid receptor interactions with heat shock protein and immunophilin chaperones.

  1997cited by this paper
• In vitro evidence that hsp90 contains two independent chaperone sites

  1997cited by this paper
• Purification of a Fatty Acid-stimulated Protein-serine/threonine Phosphatase from Bovine Brain and Its Identification as a Homolog of Protein Phosphatase 5*

  1997cited by this paper
• A Model of Protein Targeting Mediated by Immunophilins and Other Proteins That Bind to hsp90 via Tetratricopeptide Repeat Domains*

  1996cited by this paper
• Purification and partial molecular characterization of GRP94, an ER resident chaperone.

  1996cited by this paper
• Cyclophilin 40 (CyP-40), Mapping of Its hsp90 Binding Domain and Evidence That FKBP52 Competes with CyP-40 for hsp90 Binding (*)

  1996cited by this paper
• Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells.

  1996cited by this paper
• Mutational analysis of Hsp90 alpha dimerization and subcellular localization: dimer disruption does not impede "in vivo' interaction with estrogen receptor.

  1996cited by this paper
• Structure and mechanism of DNA topoisomerase II

  1996cited by this paper
• Mechanism of dimer formation of the 90-kDa heat-shock protein.

  1995cited by this paper
• Distinct functions of the 90 kDa heat-shock protein (hsp90) in oestrogen and mineralocorticosteroid receptor activity: effects of hsp90 deletion mutants.

  1995cited by this paper
• Structural and functional aspects of basic helix-loop-helix protein folding by heat-shock protein 90.

  1994cited by this paper
• Expression of recombinant human casein kinase II and recombinant heat shock protein 90 in Escherichia coli and characterization of their interactions.

  1994cited by this paper
• Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.

  1994cited by this paper
• Mutational analysis of hsp90 binding to the progesterone receptor.

  1993cited by this paper
• Conformational activation of a basic helix-loop-helix protein (MyoD1) by the C-terminal region of murine HSP90 (HSP84)

  1992cited by this paper
• Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes.

  1992cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Immunological evidence that the nonhormone binding component of avian steroid receptors exists in a wide range of tissues and species.

  1985cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• A Nucleotide-dependent Molecular Switch Controls Atp Binding at the C-terminal Domain of Hsp90 N-terminal Nucleotide Binding Unmasks a C-terminal Binding Pocket*

  year unknowncited by this paper

• HSP90 inhibitors in cancer immunotherapy: Therapeutic opportunities and challenges.

  2025cites this paper
• Targeting proteostasis for cancer therapy: current advances, challenges, and future perspectives

  2025cites this paper
• Phytochemical Profiling and Structure-Based Computational Characterization of Marrubium vulgare L. Compounds as Hsp90 Modulators

  2025cites this paper
• Advances in the structures, mechanisms and targeting of molecular chaperones

  2025cites this paper
• Comparison between conventional, grinding, and microwave synthesis of methylpyrazoles as VEGFR-2/HSP90 dual inhibitors.

  2025cites this paper
• Investigation of a cryptic ligand binding site on Plasmodium falciparum Hsp90.

  2025cites this paper
• Molecular characterization of heat shock protein 70 and 90 genes and their expression analysis in air-breathing magur catfish (Clarias magur) while exposed to zinc oxide nanoparticles

  2024cites this paper
• Targeting protein-protein interactions in drug discovery: Modulators approved or in clinical trials for cancer treatment.

  2024cites this paper
• Synthesis, molecular docking, dynamics study and preliminary cytotoxicity study of some coumarin linked imidazothiadiazoles

  2024cites this paper
• Site‐specifically Phosphorylated Hsp90C‐terminal Domain Variants Provide Access to Deciphering the Chaperone Code.

  2024cites this paper
• A Coumarin–Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins

  2023cites this paper
• Extracellular Hsp90 Binds to and Aligns Collagen-1 to Enhance Breast Cancer Cell Invasiveness

  2023cites this paper
• Synthesis, DFT calculations, and anti-proliferative evaluation of pyrimidine and selenadiazolopyrimidine derivatives as dual Topoisomerase II and HSP90 inhibitors

  2023cites this paper
• Structural and functional complexity of HSP90 in cellular homeostasis and disease

  2023cites this paper
• Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy

  2022cites this paper
• Hsp90 in Human Diseases: Molecular Mechanisms to Therapeutic Approaches

  2022cites this paper
• Recent Advances toward the Development of Hsp90 C-terminal Inhibitors.

  2022cites this paper
• Heat Shock Protein 70 and 90 Family in Prostate Cancer

  2022cites this paper
• Multiplexed Isobaric Quantitative Cross-Linking Reveals Drug-Induced Interactome Changes in Breast Cancer Cells.

  2022cites this paper
• Discovery of a Simplified Deguelin Analog as an HSP90 C-terminal Inhibitor for HER2-positive Breast Cancer.

  2021cites this paper
• Structure-Activity Relationships of Benzothiazole-Based Hsp90 C-Terminal-Domain Inhibitors

  2021cites this paper
• Role of HSP90 in Cancer

  2021cites this paper
• Tubocapsenolide A targets C-terminal cysteine residues of HSP90 to exert the anti-tumor effect.

  2021cites this paper
• Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 Dimerization

  2021cites this paper
• PNSA, a Novel C-Terminal Inhibitor of HSP90, Reverses Epithelial–Mesenchymal Transition and Suppresses Metastasis of Breast Cancer Cells In Vitro

  2021cites this paper
• Dissecting Molecular Principles of the Hsp90 Chaperone Regulation by Allosteric Modulators Using a Hierarchical Simulation Approach and Network Modeling of Allosteric Interactions: Conformational Selection Dictates Diversity of Protein Responses and Ligand-Specific Functional Mechanisms.

  2020cites this paper
• SUV39H1 is a New Client Protein of Hsp90 Degradated by Chaetocin as a Novel C-Terminal Inhibitor of Hsp90

  2020cites this paper
• Heat shock protein 90 (Hsp90) Inhibitors: An Update on Achievements, Challenges, and Future Directions.

  2020cites this paper
• Medium-Throughput Detection of Hsp90/Cdc37 Protein–Protein Interaction Inhibitors Using a Split Renilla Luciferase-Based Assay

  2020cites this paper
• Natural heat shock protein 90 inhibitors in cancer and inflammation.

  2020cites this paper
• The Hsp90 Inhibitor, Monorden, Is a Promising Lead Compound for the Development of Novel Fungicides

  2020cites this paper
• Fungal Mycotoxin Penisuloxazin A, A Novel C-terminal Hsp90 Inhibitor and Characteristics of Its Analogues on Hsp90 Function Related to Binding Sites.

  2020cites this paper
• Revisiting silibinin as a novobiocin-like Hsp90 C-terminal inhibitor: Computational modeling and experimental validation.

  2019cites this paper
• Penicisulfuranol A, a novel C‐terminal inhibitor disrupting molecular chaperone function of Hsp90 independent of ATP binding domain

  2019cites this paper
• Targeting Hsp-90 Related Disease Entities for Therapeutic Development

  2019cites this paper
• HSP90 and Its Inhibitors for Cancer Therapy: Use of Nano-delivery System to Improve Its Clinical Application

  2019cites this paper
• Widespread remodelling of proteome solubility in response to different protein homeostasis stresses

  2019cites this paper
• Structural Basis for DNA Gyrase Interaction with Coumermycin A1.

  2019cites this paper
• C-terminal modulators of heat shock protein of 90 kDa (HSP90): State of development and modes of action.

  2019cites this paper
• Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development

  2018cites this paper
• Recent developments in the chemistry of ferrocenyl secondary natural product conjugates

  2018cites this paper
• Topoisomerases as anticancer targets.

  2018cites this paper
• Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain

  2018cites this paper
• Inhibition of Heat Shock proteins HSP90 and HSP70 induce oxidative stress, suppressing cotton fiber development

  2018cites this paper
• Clinical efficiency and safety of Hsp90 inhibitor Novobiocin in avian tibial dyschondroplasia

  2018cites this paper
• In silico identification and analysis of the binding site for aminocoumarin type inhibitors in the C-terminal domain of Hsp90.

  2018cites this paper
• Molecular insights into the interaction of Hsp90 with allosteric inhibitors targeting the C-terminal domain.

  2018cites this paper
• Inhibitors and chemical probes for molecular chaperone networks

  2018cites this paper
• Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer

  2018cites this paper
• Modulation of Human Hsp90α Conformational Dynamics by Allosteric Ligand Interaction at the C-Terminal Domain

  2018cites this paper
• A Chemogenomic Screening Platform Used to Identify Chemotypes Perturbing HSP90 Pathways

  2017cites this paper
• The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease

  2017cites this paper
• Regulation of Human 69-kDa Choline Acetyltransferase Protein Stability and Function by Molecular Chaperones and the Ubiquitin-Proteasome System

  2017cites this paper
• Ferrocenyl and organic novobiocin derivatives: Synthesis and their in vitro biological activity.

  2017cites this paper
• Extracellular and Non-Chaperone Function of Heat Shock Protein-90α Is Required for Skin Wound Healing.

  2017cites this paper
• Targeting the Hsp90 C-terminal domain to induce allosteric inhibition and selective client downregulation.

  2017influential citation
• Calcyclin Binding Protein/Siah-1 Interacting Protein Is a Hsp90 Binding Chaperone

  2016cites this paper
• TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles)

  2016cites this paper
• In Vivo Conformational Dynamics of Hsp90 and Its Interactors.

  2016cites this paper
• Identification of Limonol Derivatives as Heat Shock Protein 90 (Hsp90) Inhibitors through a Multidisciplinary Approach.

  2016cites this paper
• Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors.

  2016cites this paper
• The Hsp90 Chaperone Machinery: An Important Hub in Protein Interaction Networks.

  2016cites this paper
• The Malarial Exported PFA0660w Is an Hsp40 Co-Chaperone of PfHsp70-x

  2016cites this paper
• In silico identification and computational analysis of the nucleotide binding site in the C-terminal domain of Hsp90.

  2016cites this paper
• Novel 1,6-naphthyridin-2(1H)-ones as potential anticancer agents targeting Hsp90.

  2016cites this paper
• Steroid Receptor-Associated Immunophilins: A Gateway to Steroid Signalling.

  2015cites this paper
• Targeting the C-Terminus of Hsp90 as a Cancer Therapy

  2015cites this paper
• Small Molecule Inhibitors to Disrupt Protein-protein Interactions of Heat Shock Protein 90 Chaperone Machinery

  2015cites this paper
• A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease

  2015cites this paper
• Hsp90 as a therapeutic target in endocrinology: current evidence

  2015cites this paper
• Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold.

  2015cites this paper
• Organelle-specific Hsp90 inhibitors

  2015cites this paper
• Steroid Receptor-Associated Immunophilins: Candidates for Diverse Drug-Targeting Approaches in Disease.

  2015cites this paper
• Exploiting Cancer Dependence on Molecular Chaperones: HSP90 Inhibitors Past, Present, and Future

  2014cites this paper
• Investigating the Chaperone Properties of a Novel Heat Shock Protein, Hsp70.c, from Trypanosoma brucei

  2014cites this paper
• SMYD2-dependent HSP90 methylation promotes cancer cell proliferation by regulating the chaperone complex formation.

  2014cites this paper
• Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cells

  2014cites this paper
• Identifying a C-terminal ATP binding sites-based novel Hsp90-Inhibitor in silico: a plausible therapeutic approach in Alzheimer's disease.

  2014cites this paper
• Exploiting Conformational Dynamics in Drug Discovery: Design of C-Terminal Inhibitors of Hsp90 with Improved Activities

  2014cites this paper
• A heat shock protein 90 inhibitor that modulates the immunophilins and regulates hormone receptors without inducing the heat shock response.

  2014cites this paper
• The Cornerstone of Nucleic Acid-Affecting Antibiotics in Bacteria

  2014cites this paper
• Alternate Synthesis of HSP90 Inhibitor AT13387

  2014cites this paper
• Small molecule modulators of protein-protein interactions: selected case studies.

  2014cites this paper
• Analysis of the interaction of Hsp90 with the extracellular matrix protein fibronectin (FN)

  2014cites this paper
• Structure-Activity Relationship ( SAR ) of Withanolides to Inhibit Hsp 90 for Its Activity in Pancreatic Cancer Cells

  2014cites this paper
• Identification and inhibition of C-terminal ATP-binding sites of Hsp90α through design of novel derrubone analogues as a plausible approach towards Alzheimer’s disease treatment

  2014cites this paper
• Hsp90 Binds Directly to Fibronectin (FN) and Inhibition Reduces the Extracellular Fibronectin Matrix in Breast Cancer Cells

  2014cites this paper
• Targeting heat shock proteins in cancer.

  2013cites this paper
• The regulatory mechanism of a client kinase controlling its own release from Hsp90 chaperone machinery through phosphorylation

  2013cites this paper
• The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones.

  2013cites this paper
• Probing Molecular Mechanisms of the Hsp90 Chaperone: Biophysical Modeling Identifies Key Regulators of Functional Dynamics

  2012cites this paper
• An Hsp90 modulator that exhibits a unique mechanistic profile.

  2012cites this paper
• Investigation of the Hsp90 C-terminal Binding Site, Novel Inhibitors and Isoform-Dependent Client Proteins

  2012cites this paper
• Inhibiting HSP90 to treat cancer: a strategy in evolution.

  2012cites this paper
• Heat shock protein 90 inhibitors as therapeutic agents.

  2012cites this paper
• Biflavonoids from Daphne linearifolia Hart.

  2012cites this paper
• The ‘active life’ of Hsp90 complexes☆

  2012cites this paper
• HSP90 as a platform for the assembly of more effective cancer chemotherapy.

  2012cites this paper
• Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir.

  2012cites this paper
• Functional Protein Interactions in Steroid Receptor-Chaperone Complexes

  2012cites this paper